TNF-alpha inhibitors and TB
The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a statement concerning the risk of tuberculosis with tumour necrosis factor alpha (TNF-alpha) inhibitor treatment. The MHRA published an article in the April issue of its monthly Drug Safety Update bulletin reminding healthcare professionals of the increased risk of tuberculosis in patients receiving TNF-alpha inhibitors, the recommendation for screening and monitoring patients, and that there is a patient alert card which should be given to patients. The article can be viewed on the MHRA website:
ECCO 2015: Challenging Cases
Present a challenging case at the ECCO Congress 2015 in Barcelona
SciCom opens the call for challenging cases for the ECCO Congress 2015 in Barcelona. Calls submitted should relate to one of the following three clinical dilemmas:
- Risk of cancer in chronic perianal disease
- Risk of infection occurring under biological treatment (anti-TNF, immunosuppressant)
- Loss of response to anti-TNF in paediatrics
Please note that your case does not necessarily need to be a rare case and can represent an everyday struggle.
In the selection process, priority will be given to cases reflecting one of the session titles. Please also consider how the case complements the overall programme.
CICRA Research Grants
The Crohn's in Childhood Research Association offers the following research opportunities.
Research Fellowship in Paediatric Gastroenterology: Applications are invited from interested centres in the UK - closing date for receipt of applications Thursday 6th November 2014
PhD studentship: CICRA invites applications from research groups with a proven track record of high quality output in gut immunology and inflammation or IBD genetics. Closing date for receipt of applications - Thursday 6th November 2014
Project grant: CICRA invites high quality research applications for funding up to £100,000 relevant to Crohn’s disease or ulcerative colitis in childhood. Closing date for receipt of applications Thursday 6th November 2014
Bursary grants: CICRA also gives grants of up to £400 (up to a total amount of £5,000pa) to enable UK based young Doctors still in training/nurses/final year medical students and similar persons with an interest in the area of Crohn's and colitis (IBD) to support attendance at national, international scientific/educational congresses and if considered appropriate IBD related training courses.
Application forms and further information can be obtained from the CICRA website: www.cicra.org
Questions about applying to the EME researcher-led workstream?
New funding opportunity within the EME programme
The EME Programme is accepting applications to its commissioned workstream for stratified medicine in non-cancerous conditions. The call closes on 3 June 2014. Anyone interested can register for a webinar on 25 March 2014 to learn more about the call. Further information about the EME programme remit, the commissioning brief and tips for making a successful application are available from the EME website. NETSCC strongly advises that potential applicants collaborate and plan - successful EME applications generally involve strong collaborations between an academic unit and/or NHS organisation and/or industry. Build a strong team and start to prepare your bid using your combined expertise.
You can also develop new partnerships by attending a stratified medicine event co-hosted by the EME Programme and the NIHR Office for Clinical Research Infrastructure (NOCRI) on Tuesday 1 April 2014 in central London. At this event, you will
learn from people in industry about their experience working with the NHS and researchers
hear researcher perspectives on partnering to take advantage of EME research funding awards
meet with potential partners to establish collaborations and take your funding application forward.
More information will be available later this month.
Page 1 of 3